Management of obstructive voiding dysfunction

Drugs of Today

Volumn 39, Issue 7, 2003, Pages 513-540

  Ellerkmann, R Mark ^a   McBride, Andrew ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; BACLOFEN; BETHANECHOL; CHLORPROMAZINE; DANTROLENE; DIAZEPAM; DOXAZOSIN; DOXEPIN; EPHEDRINE; FINASTERIDE; FLUPHENAZINE; HALOPERIDOL; IMIPRAMINE; ISOPRENALINE; MAPROTILINE; NORTRIPTYLINE; ORCIPRENALINE; PHENOXYBENZAMINE; PHENYLEPHRINE; PRAZOSIN; PROSTAGLANDIN DERIVATIVE; PSEUDOEPHEDRINE; SABAL EXTRACT; TAMSULOSIN; TERAZOSIN; TERBUTALINE; THIOREDOXIN; TIOTIXENE; UNINDEXED DRUG;

ASTHENIA; BLADDER EMPTYING; EJACULATION DISORDER; FEMALE; GASTROINTESTINAL SYMPTOM; GENDER; HEADACHE; HUMAN; HYPERTENSION; IMPOTENCE; LIBIDO DISORDER; MALE; MICTURITION DISORDER; ORTHOSTATIC HYPOTENSION; PELVIC DISEASE; PREVALENCE; PROSTATE HYPERTROPHY; RETROGRADE EJACULATION; REVIEW; RHINITIS; SEXUAL DYSFUNCTION; SOMNOLENCE; SYMPTOMATOLOGY; TREATMENT OUTCOME; VERTIGO;

CLINICAL TRIALS; FEMALE; HUMANS; MALE; PROSTATIC HYPERPLASIA; URETHRAL OBSTRUCTION; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URINARY RETENTION; URODYNAMICS;

EID: 0141842773     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2003.39.7.799443     Document Type: Review

References (86)

1. Groutz, A., Blaivas, J.G., Chaikin, D.C. Bladder outlet obstruction in women. Definition and characteristics. Neurourol Urodyn 2000, 19: 213-20.
2. Rees, D.L.P., Whitfield, H.N., Islam, A.K.M.S., Doyle, P.T., Mayo, M.E., Wickham, J.E.A. Urodynamic findings in adult females with frequency and dysuria. Br J Urol 1976, 47: 853-60.
3. Farrar, D.J., Osborne, J.L., Stephenson, T.P. et al. A urodynamic view of bladder outflow obstruction in the female. Factors influencing the results of treatment. Br J Urol 1976, 47: 815-22.
4. Massey, J.A., Abrams, P.H. Obstructed voiding in the female. Br J Urol 1988, 61: 36-9.
5. Stanton, S.L., Ozsoy, C., Hilton, P. Voiding difficulties in the female, prevalence, clinical and urodynamic review. Obstet Gynecol 1983, 61: 144-7.
6. Djavan, B., Larson, T.R., Blute, M.L. et al. Transurethral microwave thermotherapy. What role should it play versus medical management in the treatment of benign prostatic hyperplasia? Urology 1998, 52: 935.
7. Diokno, A.C., Brown, N.B., Goldstein, N. et al. Epidemiology of bladder emptying symptoms in elderly men. J Urol 1992, 148: 1817.
8. Girman, C.J., Jacobsen, S.J., Guess, H.A. et al. Natural history of prostatism. Relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 1995, 153: 1510.
9. Flanigan, R.C., Reda, D.J., Wasson, J.H. et al. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia. A Department of Veterans Affairs cooperative study. J Urol 1998, 160: 12.
10. Medina, J.J., Parra, R.O., Moore, R.G. The aging male patient. Med Clin North Am 1999, 83: 1212-29.
11. Barry, M.J., Fowler, F.J. Jr., O'Leary, M.P. et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992, 148: 1549-57.
12. Madsen, P.O., Iversen, P. A point system for selecting operative candidates. In: Benign Prostatic Hyperplasia. F. Hinman Jr. (Ed.). Springer-Verlag: New York 1983, 763.
13. Boyarsky, S., Jones, G., Paulson, D. et al. A new look at bladder neck obstruction by the Food and Drug Administration regulators. Guidelines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg 1976, 68: 29.
14. Bump, R.C., Mattiasson, A., Bo, K. et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction . Am J Obstet Gynecol 1996, 175: 10.
15. Nitti, V.W., Tu, L.M., Gitlin, J. Diagnosing bladder outlet obstruction in women. J Urol 1999, 161: 1535-40.
16. Tanagho, E.A., Miller, E.R. Initiation of voiding. Br J Urol 1970, 42: 175.
17. Axelrod, S.L., Blaivas, J.G. Bladder neck obstruction in women. J Urol 1987, 137: 497-9.
18. Chassagne, S., Bernier, P.A., Haab, F., Roehrborn, C.G., Reisch, J.S., Zimmern, P.E. Proposed cutoff values to define bladder outlet obstruction in women. Urology 1998, 51: 408-11.
19. Carr, L.K., Webster, G.D. Bladder outlet obstruction in women. Urol Clin North Am 1996, 23: 385-91.
20. Desmond, A.D., Ramayya, G.R. Comparison of pressure flow studies with micturitional urethral pressure profiles in the diagnosis of urinary out-flow obstruction. Br J Urol 1988, 61: 224-9.
21. DuBeau, C.E., Sullivan, M.P., Cravalho, E.G. et al. Correlations between micturitional urethral pressure profiles in the diagnosis of urinary out-flow obstruction. J Urol 1995,154: 498-503.
22. Sullivan, M.P., Yalla, S.V. Micturition profilometry. In: Female Urology, 2nd Edition. S. Raz (Ed.). W.B. Saunders: Philadelphia 1996, 132-40.
23. McGuire, E.J., Woodside, J.R., Borden, T.A. et al. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981, 126: 205-8.
24. McConnell, J.D., Berry, M.J., Bruskewitz, R.C. Benign prostatic hyperplasia. Diagnosis and treatment. Clinical practice guideline, Number 8. AHCPR Publication No. 94-0582. Agency for Health Care Policy and Research, Public Health Service: Rockville, MD.
25. Grossfeld, G.D., Coakley, F.V. The prostate gland. A clinically relevant approach to imaging. Radiol Clin North Am 2000, 38.
26. Barrett, D.M. The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: A randomized double-blind study. J Urol 1981, 126: 640.
27. Philp, N.H., Thomas, D.G., Clarke, S.J. Drug effects on the voiding cystometrogram: A comparison of oral bethanechol and carbachol. Br J Urol 1980, 52: 484.
28. Wein A.J., Malloy, T.R., Shofer, F., Raezer, D.M. The effects of bethanechol chloride on urodynamic parameters in normal women and in women with significant residual urine volumes. J Urol 1980, 124: 397-9.
29. Khanna, O.P. Disorders of micturition. Neuropharmacologic basis and results of drug therapy. Urology 1976, 8: 316.
30. Murray, K. Medical and surgical management of female voiding difficulty. In: Micturition. J.O. Drife, P. Hilton and S.L. Stanton (Eds.). Springer-Verlag: London 1990.
31. Lepor, H., Theune, C. Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms. J Urol 1995, 154: 116.
32. Kumar, A., Mandhani, A., Gogoi, S., Srivastava, A. Management of functional bladder neck obstruction in women. Use of alpha-blockers and pediatric resectoscope for bladder neck incision. J Urol 1999, 162: 2061-5.
33. Andersson K.E., Hendriksson, L., Ulmsten, U. Effects of prostaglandin E2 applied locally on intravesical and intraurethral pressures in women. Eur Urol 1978, 4: 366.
34. Delaere, K.P.J., Thomas, C.M.G., Moonen, W.A. et al. The value of intravesical prostaglandin E2 and F2 in women with abnormalities of bladder emptying. Br J Urol 1981, 53: 306.
35. Desmond, A.D., Bultitude, M.I., Hills, N.H. et al. Clinical experience with intravesical prostaglandin E2. Br J Urol 1980, 53: 357.
36. Gleason, D.M., Bottaccini, M.R., Lattimer, J.K. What does the bougie a boule calibrate? J Urol 1969, 101: 114.
37. Tanagho, E.A., McCurry, E. Pressure and flow rate as related to lumen caliber and entrance configuration. J Urol 1971, 105: 583.
38. Bhatia, N.N., Bergman, A. Use of preoperative uroflowmetry and simultaneous urethrocystometry for predicting risk of prolonged postoperative bladder drainage. Urology 1986, 28: 440-5.
39. McGuire, E.J., Leston, W., Wang, S. Transvaginal urethrolysis after obstructive urethral suspension procedures. J Urol 1989, 142: 1037-8.
40. Staton, S.L. Silastic sling for urethral sphincter incompetence in women. Brit J Obstet Gynaec 1985, 92: 747-50.
41. McGuire, E.J., Bennet, C.J., Konnak, J.A., Sonda, L.P., Savastoano, J.A. Experience with pubovaginal sling of urinary incontinence at the University of Michigan. J Urol 1987, 138: 525-30.
42. Weinbergern, M.W., Ostergard, D.R. Long-term clinical and urodynamic evaluation of the polytetrafluorethelene suburethral sling for treatment of genuine stress incontinence. Obstet Gynecol 1995, 86: 92.
43. Kelly, M.J., Kneilsen, K., Bruskewitz, R., Roskamp, D., Leach, G.E. Symptom analysis of patients undergoing modified Pereyra bladder neck suspension for stress urinary incontinence. Urology 1991, 37: 213-9.
44. Nickel, J.C., Fradet, Y., Boake, R.C. et al. and the PROSPECT Study Group. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia. Result of a 2-year randomized controlled trial. Can Med Assoc J 1996, 155: 1251.
45. Stoner, E. and the Finasteride Study Group. The clinical effects of a 5-alpha reductase inhibitor, finasteride, on benign prostatic hyperplasia. J Urol 1992, 147: 1298.
46. Rittmaster, R.S. Finasteride. N Engl J Med 1994, 330: 120-5.
47. Wilt, T.J. Howe, W., MacDonald, R. Terazosin for treating symptomatic benign prostatic obstruction: A systematic review of efficacy and adverse effects. BJU Int 2002, 89: 214-25.
48. Lepor, H., Williford, W.O., Barry, M.J. et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med 1996, 335: 533-9.
49. 1A adrenoreceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicenter studies in patients with benign prostatic obstruction. Eur Urol 1996, 29: 155.
50. Lepor, H. for the Tamsulosin Investigator Group. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Urology 1998, 51: 892.
51. Chapple, C.R., Wyndaele, J.J., Nordling, J., Boeminghaus, F. et al. Tamsulosin, the firstprostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. Eur Urol 1996, 29: 155-67.
52. Wilt, T.J., MacDonald, R., Nelson, D. Tamsulosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction. A systematic review of efficacy and adverse effects. J Urol 2002, 167: 177-83.
53. Saw palmetto for benign prostatic hyperplasia. Med Lett Drugs Ther 1999, 41: 18.
54. Wilt, T.J., Ishari, A., Stark, G., MacDonald, R., Lau, J., Mulrow, C. Saw palmetto extracts for treatment of benign prostatic hyperplasia. A systematic review. JAMA 1998, 280: 1604-9.
55. Champault, G., Patel, J.C., Bonnard, A.M. et al. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. Br J Clin Pharmacol 1984, 18: 461-2.
56. Andersson, K.E., Chapple, C.R., Hofner, K. Future drugs for the treatment of benign prostatic hyperplasia. World J Urol 2002, 19: 436-42.
57. Holtgrewe, H.L. Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia. Urology 1998, 51: 1.
58. McConnell, J.D. Benign prostatic hyperplasia. Treatment guidelines and patient classifications. Br J Urol 1995, 76(Suppl. 1): 29-46.
59. Millin, T. Retropubic prostatectomy. J Urol 1948, 59: 367.
60. Wennberg, J.E., Fowler, F.J. Jr., Timothy, R.P., Berry, M.J., Mulley, A.G. Jr. Symptom status and quality of life following prostatectomy. JAMA 1988, 259: 3018-22.
61. Ogden, C.W., Reddy, P., Johnson, H., Ramsay, J.W., Carter, S.S. Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet 1993, 341: 14-7.
62. Ramsey, E.W., Dahlstrand, C. Durability of results obtained with transurethral microwave thermotherapy in the treatment of men with symptomatic benign prostatic hyperplasia. J Endourol 2000, 14: 671-5.
63. Mulvin, D., Creagh, T., Kelly, D., Smith, J., Quilan, D., Fitzpatrick, J. Transurethral microwave thermotherapy versus transurethral catheter therapy for benign prostatic hyperplasia. Eur Urol 1994, 26: 6-9.
64. Dahlstrand, C., Geirsson, G., Fall, M., Pettersson, S. Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: Preliminary results of a randomized study. Eur Urol 1993, 23: 292-8.
65. Partoll, L.M. Voiding dysfunction and retention. In: Urogynecology and Reconstructive Pelvic Surgery. M.D. Walters and M.M. Karram (Eds.). Mosby: St. Louis 1999, 329-39.
66. Curtis, L.A., Dolan, T.S., Cespedes, R.D. Acute urinary retention and urinary incontinence. Emerg Med Clin North Am 2001, 19: 1-24.
67. Spencer, J.R., O'Conor, V.J., Schaeffer, A.J. A comparison of endoscopic suspension of the vesical neck with suprapubic vesicourethropexy for treatment of stress urinary incontinence. J Urol 1987, 137: 411-5.
68. Horbach, N.S. Suburethral sling procedures. In: UroGynecology and Urodynamics, Theory and Practice, 3rd Edition. D.R. Ostergard and A.E. Bent (Eds.). Williams and Wilkins 1991, 413-21.
69. Wang, A.C. Burch colposuspension vs. Stamey bladder neck suspension. A comparison of complications with special emphasis on detrusor instability and voiding dysfunction. J Reprod Med 1996, 41: 529-33.
70. Zimmern, RE., Hadley, H.R., Leach, G.E., Raz, S. Female urethral obstruction after Marshall-Marchetti-Krantz operation. J Urol 1987, 138: 517.
71. McDuffie, R.W., Litin, R.B., Blundon, K.E. Urethrovesical suspension (Marshall-Marchetti-Krantz): Experience with 204 cases. Am J Surg 1981, 141: 297-8.
72. Nitti, V.W., Raz, S. Obstruction following anti-incontinence procedures. Diagnosis and treatment with transvaginal urethrolysis. J Urol 1994, 152: 93-8.
73. Leach, G.E., Raz, S. Modified Pereyra bladder neck suspension after previously failed anti-incontinence surgery. Urology 1984, 23: 359-62.
74. Austin, P., Spyropoulos, E., Lotenfoe, R., Helal, M., Hoffman, M., Lockhart, J.L. Urethral obstruction after anti-incontinence surgery in women: Evaluation, methodology, and surgical results. Urology 1996, 47: 890-4.
75. Ghoniem, G.M., Elgamasy, A.N. Simplified surgical approach to bladder outlet obstruction following pubovaginal sling. J Urol 1995, 154: 181-3.
76. McLennen, M.T., Bent, A.E. Sling incision with associated vaginal wall interposition for obstructed voiding secondary to suburethral sling procedure. Int Urogyn J Pelvic Floor Dysfunc 1997, 8: 128-72.
77. Petrou, S.P., Brown, J.A., Blaivas, J.G. Suprameatal transvaginal urethrolysis. J Urol 1999, 161: 1268-71.
78. Carr, L.K., Webster, G.D. Voiding dysfunction following incontinence surgery: Diagnosis and treatment with retropubic or vaginal urethrolysis. J Urol 1997, 157: 821-3.
79. Foster, H.E., McGuire, E.J. Management of urethral obstruction with transvaginal urethrolysis. J Urol 1993, 150: 1448-51.
80. Goldman, H.B., Rackley, R.R., Appell, R.A. The efficacy of urethrolysis without re-suspension for iatrogenic urethral obstruction. J Urol 1999, 161: 196-9.
81. Amundsen, C.L., Guralnick, M.L., Webster, G.D. Variation in strategy for the treatment of urethral obstruction after a pubovaginal sling procedure. J Urol 1998, 142: 434-7.
82. Cross, C.A., Cespedes, R.D., English, S.F., McGuire, E.J. Transvaginal urethrolysis for urethral obstruction after anti-incontinence surgery. J Urol 1998, 159: 1199-201.
83. McGuire, E.J., Letson, W., Wang, S. Transvaginal urethrolysis after obstructive urethral suspension procedures. J Urol 1997, 142: 1037-8.
84. Romanzi, L.J., Blaivas, J.G. Protracted urinary retention necessitating urethrolysis following tension-free vaginal tape surgery. J Urol 2000, 164: 2022-3.
85. Webster, G.D., Kreder, K.J. Voiding dysfunction following cystourethropexy. Its evaluation and management. J Urol 1990, 144: 670-3.
86. Raz, S. (Ed.). Female Urology, 2nd Edition. W.B. Saunders Co.: Philadelphia 1996, 138.